Kolexia
Cayssials-Caylus Emilie Hématologie
Cayssials-Caylus Emilie
Hématologie
Hôpital La Miletrie
Poitiers, France
74 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde Leucémie myéloïde en phase chronique Crise blastique Polyglobulie Thrombocytémie essentielle Polyglobulie primitive essentielle Thrombocytose

Collaborateurs

Voir plus
Roy Lydia
Roy Lydia
Hôpital Henri Mondor, Créteil, France
Huguet Francoise
Huguet Francoise
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Etienne Gabriel
Etienne Gabriel
Institut Bergonié, Bordeaux, France
Nicolini Franck
Nicolini Franck
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Novartis
26 collaboration(s)
Dernière en 2023
Incyte
4 collaboration(s)
Dernière en 2023
KEPHREN PUBLISHING
2 collaboration(s)
Dernière en 2023
Amgen
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System: Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies
Essai Clinique (CHU Poitiers)   19 mars 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation.
Leukemia research   23 janvier 2024
Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group).
Bulletin du cancer   11 décembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with from Chronic Myeloid Leukemia (CML) in Blast Crisis.
International journal of molecular sciences   22 octobre 2023
TIBIOP-LMC: Innate T-cells as a Biomarker of Successful TKI Arrest in Chronic Myeloid Leukemia
Essai Clinique (CHU Poitiers)   03 août 2023
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia.
Expert review of hematology   27 juillet 2023
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
Genes   11 mai 2023
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Leukemia research   09 mai 2023